Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease
Alimentary Pharmacology & Therapeutics2013Vol. 37(6), pp. 622–629
Citations Over TimeTop 10% of 2013 papers
Fiona Cameron, Konstantinos Gerasimidis, A. Papangelou, D. Missiou, Vikki Garrick, Tracey Cardigan, E Buchanan, Andrew R. Barclay, Paraic McGrogan, Richard K. Russell
Abstract
Weight and BMI z-score improved with EEN and changes are sustained to 2 years, but height z-score did not. Seventy per cent of patients who relapsed during 2-year follow-up managed a 2nd course of EEN. The optimal therapeutic strategies for length of EEN course and to improve linear growth are awaited.
Related Papers
- → Azathioprine in the treatment of myasthenia gravis(1984)107 cited
- → IS AZATHIOPRINE NECESSARY IN RENAL TRANSPLANTATION?(1978)24 cited
- → Azathioprine Therapy in Polymyositis(1973)22 cited
- → Azathioprine hypersensitivity in a renal transplant recipient(1990)6 cited
- → Safety of azathioprine as a therapy for autoimmune disease of the liver in children and adolescent(2007)